ARTICLE | Clinical News
Nymox preclinical data
December 3, 2001 8:00 AM UTC
NYMX said that in a rat model of BPH, treatment with NX 1207 gave up to 50% reductions in prostate size compared to placebo. In addition, in vitro treatment of human prostate cancer tissue with NX 120...